In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663).

Source:http://linkedlifedata.com/resource/pubmed/id/11327589

Bioorg. Med. Chem. Lett. 2001 Apr 23 11 8 1059-62

Download in:

View as

General Info

PMID
11327589